Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation

Under the agreement, JW Pharmaceutical gains exclusive rights to develop and commercialise bofanglutide in South Korea. Credit: Gan & Lee Pharmaceuticals / PR Newswire.